POU5F1P3 is likely associated with fatty liver disease, immunodeficiency, and the sphingolipid signaling pathway in colorectal cancer, suggesting that POU5F1P3 expression regulates the progression of colorectal cancers and their clinical outcomes through the cellular immune response, signal transmission, and liver disease outbreak. This evidence concerns the gene POU5F1P3 and liver disorder.